Related Experiment Video
Updated: May 18, 2026

06:48
Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome
Published on: March 23, 2022
Haematological features in Barth syndrome
Josef Finsterer1, Marlies Frank
1Neurological Department, Krankenanstalt Rudolfstiftung, Vienna, Austria. fifigs1@yahoo.de
Current Opinion in Hematology
|October 9, 2012
Summary
Neutropenia in Barth syndrome stems from reactive oxygen species causing premature neutrophil clearance. Granulocyte colony-stimulating factor may help resolve this hematological abnormality in some patients.
Area of Science:
- Hematology
- Cell Biology
- Rare Diseases
Background:
- Barth syndrome is a rare genetic disorder with diverse clinical manifestations.
- Hematological abnormalities, particularly neutropenia, are a significant feature requiring further understanding.
Purpose of the Study:
- To review recent advances in Barth syndrome, focusing on pathogenesis, clinical presentation, diagnosis, and treatment.
- To elucidate the mechanisms underlying neutropenia in Barth syndrome.
Main Methods:
- Review of current literature on Barth syndrome.
- Analysis of neutrophil and lymphoblast characteristics in affected individuals.
- Examination of potential therapeutic interventions for neutropenia.
Main Results:
- Neutrophils in Barth syndrome exhibit phosphatidylserine exposure without apoptosis, suggesting increased clearance by macrophages due to reactive oxygen species.
- Lymphoblasts display mitochondrial abnormalities, including size variability and fragmented cristae.
- Neutropenia showed a positive response to granulocyte colony-stimulating factor in some patients.
Conclusions:
- Reactive oxygen species-induced phosphatidylserine exposure is the likely cause of neutropenia in Barth syndrome.
- Granulocyte colony-stimulating factor represents a potential therapeutic option for managing neutropenia in Barth syndrome.
More Related Videos
Related Concept Videos
Disorders of Erythrocytes
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Barrett Esophagus-I: Introduction
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
Overview of Hematopoiesis
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Hematopoiesis
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...

